← Open Payments lookup

ASHLEIGH GOODWIN: Open Payments

NPI 1336617679 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$962 in 45 payments from 21 companies in 2025. Trend: 2023 $114 · 2024 $1,287 · 2025 $962

Food & beverage: $962
CompanyPaymentsAmount
Astellas Pharma US Inc9$139
Sumitomo Pharma America, Inc.5$120
Merck Sharp & Dohme LLC4$109
Janssen Biotech, Inc.5$94
Dendreon Pharmaceuticals LLC2$63
Ethicon US, LLC3$54
Bayer Healthcare Pharmaceuticals Inc.2$44
Olympus America Inc.2$41
Novartis Pharmaceuticals Corporation1$32
ABBVIE INC.1$30

Products named: Xtandi, ERLEADA, LYNPARZA, PROVENGE, GEMTESA, ORGOVYX, Nubeqa, iTIND System.

Industry payments across TX — which companies pay providers there.